Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach-Reference-Cited by-同舟云学术

Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach

Published:2016-02-17 Issue:3 Volume:81 Page:538-552
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Borghardt Jens Markus¹²,Weber Benjamin²,Staab Alexander²,Kunz Christina²,Formella Stephan³,Kloft Charlotte¹

Affiliation:

1. Department of Clinical Pharmacy and Biochemistry; Institute of Pharmacy, Freie Universitaet Berlin; 12169 Berlin Germany

2. Translational Medicine and Clinical Pharmacology; Boehringer Ingelheim Pharma GmbH & Co. KG; Biberach Germany

3. Medicine Coordination; Boehringer Ingelheim Pharma GmbH & Co. KG; Ingelheim Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12780/fullpdf

Reference45 articles.

1. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States;Patel;Int J Chron Obstruct Pulmon Dis,2014

2. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2015 http://www.goldcopd.org/

3. Olodaterol: first global approval;Gibb;Drugs,2013

4. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis;Lipworth;Arch Intern Med,1999

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Prediction of Oral Drug Absorption;Oral Bioavailability and Drug Delivery;2023-10-10

2. Central and peripheral lung deposition of fluticasone propionate dry powder inhaler formulations in humans characterized by population pharmacokinetics;Pharmaceutical Research;2023-04-20

3. An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds;Journal of Pharmacological and Toxicological Methods;2022-05

4. Model‐based meta‐analysis of salbutamol pharmacokinetics and practical implications for doping control;CPT: Pharmacometrics & Systems Pharmacology;2022-03-22

5. Novel Pulmonary Delivery of Antiviral Drugs for Treating COVID-19 in Patients with Parkinson’s Disease;Current Drug Delivery;2022-03